ACE stock news on Anadi Algo News

Monday, June 15, 2026
DISCLAIMER: AI-generated signals are for informational purposes only. All trading and investment decisions are solely the user's responsibility.|Past performance does not guarantee future results. Trade at your own risk.|Anadi Algo is not a SEBI-registered advisor. Consult a qualified financial advisor before acting on any recommendation.|DISCLAIMER: AI-generated signals are for informational purposes only. All trading and investment decisions are solely the user's responsibility.|Past performance does not guarantee future results. Trade at your own risk.|Anadi Algo is not a SEBI-registered advisor. Consult a qualified financial advisor before acting on any recommendation.|
Stock Landing|41 matching stories

ACE Share Price, Latest News & Sentiment

Latest AI-analyzed news for ACE, along with saved share-price context, sentiment, quarterly filing summary, and related names in one page.

Stock Coverage Hub

ACE News Today

Widely covered stock

The SpaceX stock opened for trading at $150 compared with the IPO price of $135 per share.

Coverage
41
recent stories
Sources
5
distinct publishers
Bias Split
9 bullish / 4 bearish
4 neutral stories
Window
54d
recent coverage span
Saved Quote Snapshot

ACE

Last Updated
23 May 2026
Price
NA
NA
52W Range
NA - NA
exchange snapshot
PE / VWAP
PE NA
VWAP NA
Trend Read
mixed
EMA stack mixed
Business Context
Industry: NA
Sector Trail: NA
Listing Date: NA
Market Structure
F&O Eligible: No
Indices: NA
Snapshot Source: mcp+nse
Quarterly Read

Quarter ended 31 Dec 2024

Consolidated results
What This Quarter Says

This is the company's latest financial report. We can see their sales were Rs 875.11 crore and their profit was Rs 111.68 crore. Since there's no previous report to compare, we can't say if things improved or weakened this quarter.

Revenue
Rs 875.11 cr
up 0.2% vs previous filing
Profit
Rs 111.68 cr
up 4.2% vs previous filing
EPS / Finance Cost
EPS 9.38
Finance cost Rs 8.4 cr
Filing Context
Filed 8 Feb 2025, 3:35 am
Figures are taken from the saved exchange filing, not from a live request.
Quick Reader Notes
  • Revenue this quarter: Rs 875.11 cr, up 0.2% vs previous filing.
  • Profit this quarter: Rs 111.68 cr, up 4.2% vs previous filing.
  • EPS gives a quick sense of per-share earnings: 9.38.
How To Read This

Treat this block as a saved quarter snapshot. First see whether revenue and profit are improving, then read the latest news below to judge whether recent headlines support that trend or work against it.

ACE FAQ

Why is ACE in the news right now?

ACE has appeared across 41 recent stories from 5 sources, which usually means there is a real flow of fresh headlines rather than a single isolated mention.

Is ACE coverage bullish or bearish right now?

ACE coverage is currently leaning bullish, with 9 bullish, 4 bearish, and 4 neutral analyzed stories in the recent window.

Which themes are moving with ACE?

Recent ACE coverage is clustering around Financial Services and Pharmaceuticals. Related names showing up alongside ACE include DABUR, PARAS, ADANIPOWER.

How should I use this ACE news page?

Use this page as a coverage hub for ACE: start with the latest headlines, then check the dominant themes, related names, and saved market context before you form a trade or watchlist view.

Workflow View

Use ACE coverage to build a cleaner watchlist.

A stock page is most useful when it helps you slow down, compare headlines, and separate one-off noise from a repeatable setup.

This is here if you want to go deeper, not as a push.Explore Anadi
Top Story|livemint_markets3 days ago

SpaceX shares rise 11% on Nasdaq debut for market cap just shy of $2 trillion

The SpaceX stock opened for trading at $150 compared with the IPO price of $135 per share.

Neutral
0

Impact Score

Latest ACE Stock Coverage

Bias is bullish for oil marketing companies (OMCs) and bearish for upstream producers; maintain strict risk management on any geopolitical news impacting oil supply.|Quick check: ONGC bearish bias (oversold), RELIANCE bearish bias (oversold).
et_markets3 days ago-2.8

SpaceX raises $2.2 billion in Japan slice of record-breaking IPO

5 facts
This news has no bearing on the Indian metals sector; maintain focus on global commodity prices and domestic infrastructure spending for trading metals stocks.|Quick check: TATASTEEL bearish bias (oversold), HINDALCO bearish bias (oversold).
Maintain a bullish bias on select auto and auto ancillary stocks, focusing on companies with strong growth plans and favorable volume trends.|Quick check: NIFTY neutral (-7.2% 1d), MARUTI neutral (+0.4% 1d).
Maintain a neutral to slightly cautious stance on gold-related investments; consider re-evaluating positions if June data confirms a sustained outflow, with strict stop-losses.|Quick check: NIFTY neutral (-7.2% 1d), TATASTEEL bearish bias (oversold).
et_markets3 days ago-1.8

Elon Musk's net worth crosses $980 billion as blockbuster SpaceX IPO price set at $135

5 facts
Maintain a focus on Indian sector-specific news and domestic economic indicators; this global event is not a trade catalyst for Indian equities.|Quick check: SENSEX neutral, NIFTY neutral (-7.2% 1d).
Maintain a bullish bias on banking stocks; look for opportunities to accumulate quality names on minor pullbacks, with a focus on improving NIM and asset quality trends.|Quick check: HDFCBANK neutral (-0.3% 1d), YESBANK neutral (-1.7% 1d).
Maintain a bullish bias on Indian pharma stocks with strong oncology segments, focusing on companies that produce these specific drugs, with disciplined risk management.|Quick check: SUNPHARMA neutral (oversold), CIPLA neutral (+0.8% 1d).
Maintain a bullish bias on MTARTECH post-clarification, but use tight stop-losses given the recent volatility. Watch for consolidation above key support levels.|Quick check: MTARTECH neutral, PARAS neutral.
et_markets3 days ago+5.7

SpaceX to list today: Should Indian investors buy shares of Elon Musk's biggest bet after missing the IPO?

5 facts
Maintain a neutral bias for the Indian market based on this news. Focus on domestic fundamentals and technical levels for Nifty/Sensex, as this is an external event with no immediate direct impact.|Quick check: NIFTY neutral (-7.2% 1d), SENSEX neutral.
Maintain a bullish bias on defence stocks; look for accumulation opportunities on minor pullbacks.|Quick check: PARAS neutral, GRSE bearish bias (-2.3% 1d).
Maintain a cautious stance on high-beta and high-valuation Indian tech stocks; consider defensive sectors if global tech sentiment deteriorates.|Quick check: MARUTI neutral (+0.4% 1d), TATAMOTORS neutral (-1.2% 1d).
Maintain a cautious stance on Indian pharma stocks with significant US export exposure; prioritize companies with strong compliance records.|Quick check: DABUR bearish bias (-0.8% 1d), SUNPHARMA neutral (oversold).
Maintain a cautious stance on Dabur India (DABUR) due to regulatory uncertainty; consider short-term bearish positions or avoiding fresh longs until clarity emerges, with strict stop-losses.|Quick check: DABUR bearish bias (-0.8% 1d), SUNPHARMA neutral (oversold).
For pharma, look for confirmation of buying interest in TORNTPHARM. For ALLIEDBL and ZEEL, consider short-term long positions with strict stop-losses, given these are analyst-driven calls.|Quick check: ALLIEDBL neutral, TORNTPHARM bullish bias (+3.0% 1d).
Consider a tactical long bias in precious metals and related Indian commodity stocks, with strict stop-losses based on geopolitical news flow.|Quick check: MCX neutral (oversold), NIFTY neutral (-7.2% 1d).
For pharma, maintain a 'buy on dips' strategy, focusing on companies with strong product pipelines and regulatory approvals, as the broader market sentiment improves.|Quick check: NIFTY neutral (-7.2% 1d), SENSEX neutral.
Maintain a bullish bias on select power sector stocks and consider long positions in companies with strong fundamentals, but be mindful of crude oil price volatility and its potential impact on input costs.|Quick check: ACE neutral (+0.0% 1d), MOIL neutral.